Aerovate Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $348k | 15k | 22.61 |
| 2023-09-30 | $52k | 3.8k | 13.52 |
| 2023-06-30 | $58k | 3.4k | 17.03 |
| 2023-03-31 | $94k | 4.7k | 19.99 |
| 2022-12-31 | $113k | 3.9k | 29.20 |
| 2022-09-30 | $6.0k | 389 | 15.42 |
| 2022-06-30 | $63k | 4.0k | 15.66 |
| 2022-03-31 | $105k | 5.8k | 18.14 |